510(k) Report

510(k) · Cleared

Recalled · Class II · 2020

Advia Chemistry Enzymatic Creatinine_2

K070727510(k) TraditionalCleared Aug 3, 2007141-day reviewClass II21 CFR 862.1225Recalls 5

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Medical Solutions Diagnostics · JFY Enzymatic Method, Creatinine

Cleared on Aug 3, 2007 as substantially equivalent to K973993 (Randox Laboratories, Ltd., 1998) and 1 other predicate after a 141-day review. Its family tree reaches back 1 generation to 1998. 4 later devices descend from it. It has been recalled 5 times.

Decided
Aug 3, 2007
Review
141 days
Class
Class II
Product code
JFY
Recalls
5
Predicates
2

Its longest line of descent runs back 1 generation to K973993 (1998). 2 ancestors in all. 4 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1999: 1 other ancestor2021: 1 descendant cleared2016: 1 descendant cleared2024: 1 descendant cleared2025: 1 descendant clearedK973993 · Randox Creatinine · Randox Laboratories, Ltd. · 19981995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 2 descendants2 generations forward: 1 descendant3 generations forward: 1 descendant K973993 · Randox Creatinine · Randox Laboratories, Ltd. · 19980
  1. Root · 1 generation backK973993 Randox CreatinineRandox Laboratories, Ltd. · 1998
  2. This deviceK070727 Advia Chemistry Enzymatic Creatinine_2Siemens Medical Solutions Diagnostics · 2007
  3. Descendant · cites it directly · 2 of its ownK161494 Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator…Siemens Healthcare Diagnostics, Inc. · 2016 · Recalled
  4. Descendant · 2 generations on · 1 of its ownK242685 Atellica® CH Creatinine_3 (Crea3)Siemens Healthcare Diagnostics, Inc. · 2024
  5. Descendant · 3 generations on · 0 of its ownK251058 Tru Kidney Health Test Panel; Tru AnalyzerTruvian Health · 2025
  6. Descendant · cites it directly · 0 of its ownK212223 Atellica CH Enzymatic Creatinine_3 (ECre3)Siemens Healthcare Diagnostics, Inc. · 2021

Most influential descendants

Showing 4 of 4 · See all
  • K161494Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator (CHEM CAL)Siemens Healthcare Diagnostics, Inc. · 2016 · cites it directly2descendants
  • K242685Atellica® CH Creatinine_3 (Crea3)Siemens Healthcare Diagnostics, Inc. · 2024 · 2 generations on1descendant
  • K251058Tru Kidney Health Test Panel; Tru AnalyzerTruvian Health · 2025 · 3 generations on0descendants
  • K212223Atellica CH Enzymatic Creatinine_3 (ECre3)Siemens Healthcare Diagnostics, Inc. · 2021 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K973993Randox CreatinineRandox Laboratories, Ltd.1998—
0 (this device)K070727Advia Chemistry Enzymatic Creatinine_2Siemens Medical Solutions Diagnostics2007—
+1K161494Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator (CHEM CAL)Siemens Healthcare Diagnostics, Inc.20161
+2K242685Atellica® CH Creatinine_3 (Crea3)Siemens Healthcare Diagnostics, Inc.2024—
+3K251058Tru Kidney Health Test Panel; Tru AnalyzerTruvian Health2025—
+1K212223Atellica CH Enzymatic Creatinine_3 (ECre3)Siemens Healthcare Diagnostics, Inc.2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
202110
202410
202510
FIG. 1 — Lineage of K070727, 1998–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JFY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JFY device

  1. #1 K252619 Qscheck Uisacrscore 12.4 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K973993Randox Creatinine
Summary page 1
…Enzymatic Creatinine Common name Creatinine Test System Creatinine Test System 510(k) Number k973993 k991576 Manufacturer Siemens Medical Solutions Siemens Medica…
Randox Laboratories, Ltd.1998—
*K991576Additional Assays for the Bayer Advia 1650 Chemistry System
Summary page 1
…Common name Creatinine Test System Creatinine Test System 510(k) Number k973993 k991576 Manufacturer Siemens Medical Solutions Siemens Medical Solutions…
Bayer Corp.19993

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K161494Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator (CHEM CAL)Siemens Healthcare Diagnostics, Inc.20162
K212223Atellica CH Enzymatic Creatinine_3 (ECre3)Siemens Healthcare Diagnostics, Inc.20210

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 4, 2020Class IIZ-2283-2020Device DesignThe presence of N-acetyl-p-benzoquinone imine (NAPQI), a metabolite of acetaminophen, may cause interference in certain chemistry assays when testing patient samples.
May 4, 2020Class IIZ-2282-2020Device DesignThe presence of N-acetyl-p-benzoquinone imine (NAPQI), a metabolite of acetaminophen, may cause interference in certain chemistry assays when testing patient samples.
Dec 18, 2019Class IIZ-1230-2020Under Investigation by firmThere is a potential for falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology. Interference has not been observed with the creatinine Jaffe methodology.
Dec 18, 2019Class IIZ-1231-2020Under Investigation by firmThere is a potential for falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology. Interference has not been observed with the creatinine Jaffe methodology.
Mar 17, 2016Class IIZ-1654-2016Device DesignSiemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may occur on samples…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K161494 (Siemens Healthcare Diagnostics, Inc., 2016) has gone furthest, with 2 descendants of its own.

How does its category compare?

All JFY devices

JFY Enzymatic Method, Creatinine: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · JFY

2in 2021

2007: 82008: 42009: 32011: 22014: 22016: 12017: 12018: 22019: 22021: 22026 (partial year): 1
2007high 8 (2007) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JFY

59in 2009

2007: 193 days median2008: 170 days median2009: 59 days median
2007high 193 (2007) · low 59 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JFY

1in 2013

2008: 22009: 32010: 32013: 1
2007high 3 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JFY

61in 2025

2007: 12008: 42009: 222010: 222011: 422012: 242013: 392014: 42015: 72016: 162017: 162018: 342019: 562020: 342021: 572022: 92023: 362024: 342025: 61
2007high 61 (2025) · low 1 (2007)2025

MAUDE reports naming product code JFY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007819301
2008417024
2009359322
20100—322
20112—042
20120—024
20130—139
20142—04
20150—07
20161—016
20171—016
20182—034
20192—056
20200—034
20212—057
20220—09
20230—036
20240—034
20250—061
20261—0—

What is it indicated for?

For in vitro diagnostic use in the quantitative determination of creatinine in human serum, plasma, and urine on the ADVIA Chemistry Systems. Such measurements are used in the diagnosis and treatment of renal diseases, and in monitoring renal dialysis.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K070727: Advia Chemistry Enzymatic Creatinine_2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070727

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026